British Society of Rheumatology guideline working group response to European Medicines Agency safety update on Hydroxychloroquine
Russell, Mark D Dey, Mrinalini Flint, Julia Davie, Philippa Allen, Alexander Crossley, Amy Frishman, Margreta Gayed, Mary Hodson, Kenneth Khamashta, Munther
Russell, Mark D
Dey, Mrinalini
Flint, Julia
Davie, Philippa
Allen, Alexander
Crossley, Amy
Frishman, Margreta
Gayed, Mary
Hodson, Kenneth
Khamashta, Munther
Abstract
No abstract available
MIDER Authors
Affiliations
King's College London; University of Liverpool; Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust; Sandwell and West Birmingham NHS Trust; et al.
Citations
Altmetric:
Date
2024-02-01
Type
Article
Subject
Collections
Citation
Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, Frishman M, Gayed M, Hodson K, Khamashta M, Moore L, Panchal S, Piper M, Reid C, Saxby K, Schreiber K, Senvar N, Tosounidou S, van de Venne M, Warburton L, Williams D, Yee CS, Gordon C, Giles I. British Society of Rheumatology guideline working group response to European Medicines Agency safety update on Hydroxychloroquine. Rheumatology (Oxford). 2024 Feb 1;63(2):e37-e38. doi: 10.1093/rheumatology/kead384